• Proactive will provide editorial coverage of BetterLife’s news releases, generate feature articles based on interviews with company executives
  • Psychedelic Finance will provide an expanded marketing campaign, including social media support, market performance and news features
  • BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals
  • BetterLife Pharma Inc. (BETR) is up 8.77 per cent and is trading at C$0.31 at 12:07 pm ET

BetterLife Pharma Inc. (BETR) has retained Proactive Investors and psychedelic finance to broaden its reach with global investors and build market awareness.

Proactive will provide editorial coverage of BetterLife’s news releases, generate feature articles based on interviews with company executives, and produce video interviews.

With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage with investors.

Psychedelic Finance will provide an expanded marketing campaign, including social media support, market performance and news features.

Proactive Investors enable companies and investors to connect intelligently.

Proactive is one of the fastest-growing financial media portals in the world, providing breaking news, commentary and analysis on hundreds of listed companies and pre-IPO businesses across the globe, 24/7.

Psychedelic Finance operates a marketing company for its private and public partners, building strategic campaigns leveraging video, media and strategic introductions to its network.

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies.

BetterLife Pharma Inc. (BETR) is up 8.77 per cent and is trading at C$0.31 at 12:07 pm ET.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.